Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II
- PMID: 2543972
- PMCID: PMC287270
- DOI: 10.1073/pnas.86.12.4367
Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II
Abstract
A dual affinity fusion concept has been developed in which the gene encoding the desired product is fused between two flanking heterologous genes encoding IgG- and albumin-binding domains. Using sequential IgG and serum albumin affinity chromatography, a full-length tripartite fusion protein is obtained. This approach was used to recover a full-length fusion product in Escherichia coli containing the human insulin-like growth factor II (IGF-II). Surprisingly, the recombinant IGF-II showed increased stability against proteolytic degradation in E. coli when produced as a dual affinity fusion protein, as compared to an N-terminal fusion protein. After site-specific cleavage of the tripartite fusion protein, IGF-II molecules with immunological and receptor binding activity were obtained without renaturation steps. The results demonstrate that proteins can fold into biologically active structures, even if provided with large flanking heterologous protein domains. The concept was further used to characterize the specific degradation of recombinant IGF-II in this heterologous host.
Similar articles
-
High-level expression of human insulin-like growth factor II in Escherichia coli.J Biotechnol. 1990 Mar;13(4):293-304. doi: 10.1016/0168-1656(90)90077-o. J Biotechnol. 1990. PMID: 1366560
-
Hyperproduction of polyhedrin-IGF II fusion protein in silkworm larvae infected with recombinant Bombyx mori nuclear polyhedrosis virus.J Gen Virol. 1987 Oct;68 ( Pt 10):2599-606. doi: 10.1099/0022-1317-68-10-2599. J Gen Virol. 1987. PMID: 3312489
-
Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureus.J Biotechnol. 1990 Jun;14(3-4):423-37. doi: 10.1016/0168-1656(90)90123-s. J Biotechnol. 1990. PMID: 1366914
-
Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.DNA Cell Biol. 1997 Jul;16(7):883-92. doi: 10.1089/dna.1997.16.883. DNA Cell Biol. 1997. PMID: 9260931
-
Molecular aspects of insulin-like growth factors, their binding proteins and receptors.Baillieres Clin Endocrinol Metab. 1988 Nov;2(4):1069-85. doi: 10.1016/s0950-351x(88)80030-2. Baillieres Clin Endocrinol Metab. 1988. PMID: 2855823 Review.
Cited by
-
Sandwiched-fusion strategy facilitates recombinant production of small labile proteins.Protein Sci. 2021 Mar;30(3):650-662. doi: 10.1002/pro.4024. Epub 2021 Jan 29. Protein Sci. 2021. PMID: 33433908 Free PMC article.
-
Protein fusion tags for efficient expression and purification of recombinant proteins in the periplasmic space of E. coli.3 Biotech. 2016 Jun;6(1):44. doi: 10.1007/s13205-016-0397-7. Epub 2016 Feb 4. 3 Biotech. 2016. PMID: 28330113 Free PMC article. Review.
-
In vivo degradation of secreted fusion proteins by the Escherichia coli outer membrane protease OmpT.J Bacteriol. 1990 Jan;172(1):491-4. doi: 10.1128/jb.172.1.491-494.1990. J Bacteriol. 1990. PMID: 2403549 Free PMC article.
-
Strategies for achieving high-level expression of genes in Escherichia coli.Microbiol Rev. 1996 Sep;60(3):512-38. doi: 10.1128/mr.60.3.512-538.1996. Microbiol Rev. 1996. PMID: 8840785 Free PMC article. Review.
-
Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo.MAbs. 2021 Jan-Dec;13(1):1893888. doi: 10.1080/19420862.2021.1893888. MAbs. 2021. PMID: 33691596 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical